Risk Factors for Postpartum Depression

EP: 1.Defining Postpartum Depression

EP: 2.Recognizing and Differentiating Postpartum Depression

EP: 3.Impact on Quality of Life in Postpartum Depression

Now Viewing

EP: 4.Risk Factors for Postpartum Depression

Video content above is prompted by the following:

This segment identifies both obvious and subtle risk factors for developing perinatal mood and anxiety disorders, helping clinicians recognize vulnerable populations who may benefit from closer monitoring and earlier intervention. While previous mental health history and prior postpartum depression are well-known risk factors, the experts emphasize several “under the radar” populations that require attention. These include individuals who have recently lost a parent while becoming parents themselves, those with histories of childhood trauma that may resurface during the transition to parenthood, and patients who have abruptly discontinued psychiatric medications either by choice or on clinical advice.

The discussion addresses the controversial topic of medication use during pregnancy and lactation, with experts expressing frustration about unnecessary medication cessation. The panel emphasizes the importance of conducting thorough risk-benefit analyses, comparing the minimal risks of most psychiatric medications during pregnancy against the significant risks of untreated mental health conditions. They stress that there are no psychiatric medications known to cause the adverse outcomes associated with untreated depression, such as low birth weight, preeclampsia, gestational diabetes, or preterm birth.

A particularly concerning pattern involves patients being placed on subtherapeutic doses of medications in an attempt to minimize exposure, which creates a “double risk” scenario where patients experience both medication exposure and the risks of undertreated mental illness. The experts advocate for proper therapeutic dosing and emphasize that the goal should be optimal treatment of the mother’s mental health, which ultimately benefits both maternal and infant outcomes. This approach requires educating both patients and providers about the relative safety of psychiatric medications during pregnancy and the serious consequences of untreated mental health conditions.